跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 38 条关于
“Duobody”
全部
38
临床试验
8
药物
13
机构
0
资讯
17
去年
Epcoritamab Combination Shows High Response Rates in Follicular Lymphoma
去年
Epcoritamab Shows Durable Responses in DLBCL Trials
3年前
Genmab and AbbVie Submit Regulatory Applications for Epcoritamab Bispecific Antibody in Relapsed/Refractory B-Cell Lymphomas
11个月前
CD40-Targeted Therapies Advance Toward First Approval by 2027 with Over 35 Candidates in Clinical Development
10个月前
Genmab Presents Pivotal Phase 3 Data for Epcoritamab at ASH 2025, Expanding Treatment Options Across B-Cell Malignancies
去年
Genmab to Present Extensive Epcoritamab Clinical Data at 2025 European Hematology Association Congress
去年
Pipeline Analysis Reveals 20+ Drug Candidates for c-MET+ NSCLC Treatment
去年
SanyouBio Launches Comprehensive Suite of 73 Bispecific Antibody Reference Products to Accelerate Drug Development
去年
Bispecific Antibodies Emerge as Promising Immunotherapy Backbone in Cancer Treatment
5个月前
Hemab Therapeutics Files for NASDAQ IPO to Advance Bleeding Disorder Therapies
第 1 页,共 2 页
上一页
下一页